普雷克萨斯 PLXS 深 沪
等待开盘 11-04 09:30:00 美东时间
141.265
+1.365
+0.98%
华盛通- 最 高142.11
- 今 开139.12
- 成交量 5.59万股
- 最 低 137.8797
- 昨 收 139.90
- 总市值 38.27亿
- 52周最高 172.89
- 市盈率 静 22.57
- 换手率 0.21%
- 52周最低 103.43
- 委 比 -99.27%
- 总股本 2709.00万
- 历史最高 172.89
- 量 比 0.46
- 振 幅 3.02%
- 历史最低 19.63
- 每 手 1
- 风险率 13.67%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 升至45美元！英特尔获多家机构上调目标价；大摩上调拖拉机供应公司(TSCO)评级至"标配"，目标价升至60美元
今日重点评级关注：HC Wainwright & Co.：维持Alto Neuroscience"买入"评级，目标价从10美元升至50美元；RBC Capital：维持Precision Drilling"跑赢大市"评级，目标价从110美元升至117美元
10-27 09:45
华尔街顶级分析师最新研判：Coinbase、eBay获评级上调
华尔街最受关注、对市场走势有影响的研究评级报告现已汇总。以下是由 The Fly 整理的今日投资者需重点关注的研报观点。 五大评级上调个股 eBay（股...
10-24 23:00
Benchmark Reiterates Buy on Plexus, Maintains $165 Price Target
Benchmark analyst David Williams reiterates Plexus (NASDAQ:PLXS) with a Buy and maintains $165 price target.
10-24 18:35
Plexus Sees Q1 Sales of $1.050B-$1.090B vs $1.049B Est
Plexus (NASDAQ:PLXS) Sees Q1 Sales of $1.050B-$1.090B vs $1.049B Est
10-23 04:46
Plexus shares are trading higher after the company reported better-than-expected Q4 financial results.
Plexus shares are trading higher after the company reported better-than-expecte...
10-23 04:35
Plexus Sees Q1 Adj EPS $1.66-$1.81 vs $1.79 Est
Plexus (NASDAQ:PLXS) is looking for Q1 Adj EPS of $1.66-$1.81 vs $1.79 analyst estimate..
10-23 04:18
Earnings Scheduled For October 22, 2025
Companies Reporting Before The Bell • Barclays (NYSE:BCS) is estimated to repor...
10-22 16:32
Cartesian Growth II Signs Framework with PLXSUR
Cartesian Growth II ( ($RENEF) ) has provided an announcement. On October 16, 2...
10-17 18:58
Plexus Sets Fiscal Fourth Quarter and Fiscal Year 2025 Earnings Release Date
Plexus Corp. announced it will release its fiscal fourth quarter and 2025 fiscal year results on October 22, 2025. A conference call to discuss these results will be held on October 23, 2025, at 8:30 a.m. Eastern Time. The call and accompanying slides will be available via webcast on the company’s investor relations website. An archive of the webcast will be available for 12 months.
10-01 20:15
美股大行评级 | 潜在涨幅1650.0%！Ascendiant Capital维持GRI Bio"买入"评级，目标价上调至35美元
今日重点评级关注：Ascendiant Capital：维持GRI Bio"买入"评级，目标价从34美元升至35美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从7.5美元升至7.75美元
09-23 09:52
